Health
1 read
Uncertainty Surrounds FDA Decision on Moderna's mRNA Flu Vaccine for Seniors

Want the full story?
Read the complete article at KTSM
AI Summary
An FDA advisory panel has recommended the use of Moderna's mRNA flu vaccine for older adults, but the absence of a permanent vaccine chief and commissioner raises questions about the decision-making process. This recommendation is significant as it could enhance flu prevention among vulnerable populations, particularly seniors who are at higher risk for severe illness. The timeline for a final decision remains unclear, leaving many in the healthcare community and potential vaccine recipients in anticipation of the next steps.
health fda flu vaccine moderna
People & Organizations
FDAModerna